Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: 0.75% HYPERBARIC ROPIVACAINE: 2ML OF INTRATHECAL HYPERBARIC ROPIVACAINE (0.75%) IS ADMINISTERED UNDER SUBARACHNOID BLOCK FOR DAY CARE PERINEAL SURGERIES AND THE PATIENT IS MONITORED FOR
Sponsors
DR ASHOK KULASEKAR
Eligibility
Inclusion criteria
Inclusion criteria: 1.American society of Anaesthesiologists(ASA) grade I-II, 2.Age group between 18-65 years of both sexes. 3. Scheduled for Perineal surgeries under spinal Anaesthesia with expected duration of surgery less than 90 minutes.
Exclusion criteria
Exclusion criteria: 1.Patient refusal 2.History of allergy to test drug 3.Post spinal surgeries, spinal deformities, skin sepsis in lumbar region, patient with pre-existing neurological disorders 4.coagulopathy 5.Dysrhythmia 6.Major Hepatic, renal and cardiovascular dysfunction. 7.BMI >35 8.Height 9.Surgeries involving major blood loss.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of motor blockTimepoint: Patient is placed in sitting position for 15 minutes following the test drug administration via subarachnoid block .Duration of motor block will be assessed from baseline-15 minutes from the time of administering the test drug, and 20 minutes, followed by every 30 minutes interval upto 200 minutes. | — |
Secondary
| Measure | Time frame |
|---|---|
| Highest level of sensory blockTimepoint: Duration of sensory block will be assessed from baseline-15 minutes from the time of administering the test drug, and 20 minutes, followed by every 30 minutes interval upto 200 minutes.;To assess Hemodynamic changes and side effects, if anyTimepoint: Patients heart rate, NIBP, SPO2 will be monitored at 3 minute interval up to 15 minutes then every 5 minutes up to 60 minutes then every 10 minutes till the end of the procedure. | — |
Countries
India
Contacts
Public ContactDR ASHOK KULASEKAR
CHETTINAD ACADEMY OF RESEARCH AND EDUCATION
Outcome results
None listed